<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments

Wound Care

A Downward Slide: Q220 Infection Prevention Vascular Access Recap

Q220 reflects the full impact of COVID-19, driving a downward slide in all segments For Q220, according ...

Neuro Therapies

Cerenovus: Becoming a Key Player in Stroke: An Interview with Mark Dickinson

Mark Dickinson, Worldwide President of Cerenovus, discusses the Company’s focus on patients, innovation ...

Orthobiologics

COVID Clobbers Companies: Q220 US Joint Fluid Replacement Market Recap

Heavy-weight contender COVID-19 landed some brutal blows to revenue in Q220, but companies look for bett...

Wound Care

Major Shrinkage: Q220 Advanced Wound Care Market Recap

In Q220, all geographies experienced shrinkage in their AWC revenues with Single-use NPWT showing the sh...

Neuro Therapies

Growth Strategies Amid COVID-19: An Interview with Abbott's Keith Boettiger

Keith Boettiger, Vice President, Neuromodulation, Abbott discusses COVID-19 and the Company’s strategies...

SmartTRAK News

Meet Tim Patrick - Senior Manager of Corporate Accounts

We are pleased to announce that Tim Patrick has joined the team at SmartTRAK as Senior Manager of Corpor...

Wound Care

Increased COVID Headwinds Shut Down Procedures: Q220 Trauma Market Recap

Headwinds increased in Q2 as COVID-19 shut down elective procedures and stay-at-home orders impacted tra...

Wound Care

The Market Collapses: Q220 US Surgical Matrices Recap

The US Surgical Matrices Market collapsed in Q220, achieving sales of $227.3MM, off -39.4% YoY, as the e...

Wound Care

A Precipitous Drop: Q220 US Hemostats and Sealants Market Recap

The US market for Hemostats and Sealants dropped precipitously by -32.4% YoY in Q220, as the effects of ...

1
...
53 54 55
...
96